Medicare just unveiled negotiated price cuts on 15 expensive drugs, projected to save enrollees hundreds of millions of dollars. Read the fine print on everything else changing at the same time, and the overall bill for a lot of retirees is still headed higher, not lower.


Sponsored by Porter & Co.

Trump’s secret China deal

President Trump just returned from Beijing with the most powerful business delegation in American history…

Elon Musk. Nvidia’s Jensen Huang. Apple’s Tim Cook. Treasury Secretary Scott Bessent and the CEOs of CitiBank, BlackRock, and Goldman Sachs.

The media covered the handshakes, the state banquet, the 200 Boeing jets that China agreed to buy.

But, of course, they missed the real story.

Because while the world watched the pageantry, I believe something far more consequential was being negotiated behind closed doors.

Trump wasn't in Beijing to talk about soy beans. He was there to secure America's hemispheric grip on the most critical resource of the 21st century.

So precious, he desperately needs it to reverse the decline of the U.S. dollar. And so powerful, Vladimir Putin has said whoever controls it will "become the ruler of the world."

No one seems to be asking why Trump brought the CEOs of the world's most powerful technology and energy companies onto Air Force One.

Or what those men – who between them control more capital than most nations – were really there to negotiate.

And nobody has connected what went down in Beijing to a landmark pact signed by 13 nations in Washington just months ago – a pact designed to cut China out of the biggest investment wave in financial history.

But I have.

And what I've uncovered could impact everything about your financial future – from your stock portfolio to your retirement account to the purchasing power of every dollar you've saved.

In my new documentary, I expose exactly what Trump is really doing, how he has completely bypassed Congress to make it happen – and the five mission-critical assets sitting at the heart of his shocking, $3 trillion gambit.

Go here for the full story.

Good investing,

Porter Stansberry


The Drug Price Cuts Are Real, for Some People

The Centers for Medicare & Medicaid Services released the negotiated "maximum fair prices" for 15 high-cost Part D drugs, set to take effect January 1, 2027. CMS projects the negotiated prices will save enrollees an estimated $685 million in out-of-pocket costs under the standard benefit design. That's genuine savings, but it only applies directly to people taking one of those specific 15 medications. For everyone else on Medicare, this announcement doesn't touch their bill at all.

Meanwhile, the Structure Around It Is Getting More Expensive

At the same time these cuts were announced, other Part D numbers for 2027 are already finalized and moving the other way. The annual out-of-pocket cap is rising to $2,400, and the standard deductible is climbing to $700. Those are the costs that hit before any negotiated drug discount even applies, and both are going up for every Part D enrollee, regardless of which medications they take.

The Premium Is Headed Up Too

The standard Medicare Part B premium is projected to rise to around $209.50 a month in 2027, up from the confirmed $202.90 in 2026. That figure isn't official yet, the government won't finalize Part B premiums and deductibles until around November, so treat it as a preview rather than a locked-in number. But the direction of the projection lines up with everything else here: deductible up, out-of-pocket cap up, premium trending up, with drug savings narrowly targeted at a specific list of medications.

Final Take

A headline about negotiated drug price cuts is easy to read as "Medicare costs are coming down." For most enrollees, that's not quite what's happening. Unless you or someone in your household is taking one of the 15 specific drugs covered by these new negotiated prices, the parts of your Medicare bill that apply to everyone, the deductible, the out-of-pocket cap, and likely the premium, are still moving higher for 2027. It's worth celebrating the savings where they're real, and worth checking your own numbers before assuming they apply to you.


Written by Deniss Slinkins
Millionaire Core